Michael Gelband’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Sell
25,461
-53,566
-68% -$3.85M 0.01% 783
2026
Q1
$4.49M Sell
79,027
-46,725
-37% -$3.19M 0.04% 476
2025
Q4
$9.16M Buy
+125,752
New +$7.59M 0.07% 283
2025
Q3
Sell
-37,596
Closed -$1.61M 1676
2025
Q2
$1.61M Buy
37,596
+28,908
+333% +$1.01M 0.01% 818
2025
Q1
$355K Buy
+8,688
New +$324K ﹤0.01% 1197
2024
Q3
Sell
-107,952
Closed -$4.91M 1749
2024
Q2
$4.91M Buy
+107,952
New +$5.48M 0.03% 413
2022
Q4
Sell
-5,453
Closed -$298K 1765
2022
Q3
$298K Buy
+5,453
New +$326K ﹤0.01% 1526
2022
Q2
Sell
-3,410
Closed -$230K 2069
2022
Q1
$230K Sell
3,410
-27
-0.8% -$1.58K ﹤0.01% 1851
2021
Q4
$232K Buy
+3,437
New +$240K ﹤0.01% 1763
2020
Q2
Sell
-51,323
Closed -$742K 1834
2020
Q1
$742K Buy
51,323
+40,037
+355% +$884K 0.04% 368
2019
Q4
$312K Buy
+11,286
New +$250K 0.01% 1131

Other funds holding ESTA

Michael Gelband's ESTA Position: Q2 2026 in Review

Michael Gelband reduced its Establishment Labs (ESTA) stake by 68% in Q2 2026, selling an estimated $3.85M and leaving 25,461 shares worth $2.18M. The position accounts for 0.01% of the portfolio, ranked #783.

Michael Gelband first reported a position in ESTA in Q4 2019 and has held it in 11 quarters since. The position peaked at $9.16M in Q4 2025. 196 funds tracked by Wall St. Rank hold ESTA as of Q2 2026.

  • Michael Gelband held 25,461 shares of Establishment Labs worth $2.18M as of Q2 2026.
  • Michael Gelband sold 53,566 Establishment Labs shares in Q2 2026, an estimated $3.85M.
  • Establishment Labs made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #783 holding.
  • Michael Gelband first reported a position in Establishment Labs in Q4 2019 and has held it in 11 quarters since.
  • Michael Gelband's Establishment Labs position peaked at $9.16M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Establishment Labs as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.